3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
2
Lennox Gastaut Syndrome
2
Epilepsies, Myoclonic
2
Prostatic Neoplasms
1
Neoplasms
1
Marijuana Abuse
1
Liver Cirrhosis
1
Glioblastoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Pain
1
Breast Carcinoma In Situ
1
Behavior
1
Interventions
Cannabidiol
2
Solutions
1
Levetiracetam
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Seizures
×
Cannabidiol
×
90 days
×
Clear all
NCT05485831
2026-06-03
EpiTALY
Jazz Pharmaceuticals
Active not recruiting
111 enrolled
NCT05864846
2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4
Completed
79 enrolled